Werbung
Werbung

ACHC

ACHC logo

Acadia Healthcare Company, Inc.

13.53
USD
Gesponsert
+0.09
+0.68%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Vor-Markt

13.54

+0.01
+0.04%

ACHC Ergebnisberichte

Positives Überraschungsverhältnis

ACHC übertreffen die 25 der letzten 39Schätzungen.

64%

Nächster Bericht

Datum des nächsten Berichts
25. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$817.68M
/
$0.20
Implizierte Änderung von Q3 25 (Revenue/ EPS)
-3.98%
/
-72.22%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+5.61%
/
-68.75%

Acadia Healthcare Company, Inc. earnings per share and revenue

On 05. Nov. 2025, ACHC reported earnings of 0.72 USD per share (EPS) for Q3 25, beating the estimate of 0.68 USD, resulting in a 5.25% surprise. Revenue reached 851.57 million, compared to an expected 862.65 million, with a -1.28% difference. The market reacted with a -2.03% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 15 analysts forecast an EPS of 0.20 USD, with revenue projected to reach 817.68 million USD, implying an decrease of -72.22% EPS, and decrease of -3.98% in Revenue from the last quarter.
FAQ
For Q3 2025, Acadia Healthcare Company, Inc. reported EPS of $0.72, beating estimates by 5.25%, and revenue of $851.57M, -1.28% below expectations.
The stock price moved down -2.03%, changed from $20.68 before the earnings release to $20.26 the day after.
The next earning report is scheduled for 25. Feb. 2026.
Based on 15 analysts, Acadia Healthcare Company, Inc. is expected to report EPS of $0.20 and revenue of $817.68M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung